CD68 and cancer: Moreover, a greater number of immune cells (PD-1+ cells and CD68+CD163_ macrophages) within 30 μm of cancer cells were observed among responders than among nonresponders (Fig. 5b), whereas no significant difference in tertiary lymphoid structure (TLS) was found (Supplementary Fig. 3).